Sánchez-Hernández JA, Benítez-Alonso EO, Rivera-Tapia JA

Language: Spanish
References: 15
Page: 238-243
PDF size: 93.90 Kb.

ABSTRACT

Objective: To analyze and demonstrate the link between the use of intrauterine device (IUD) and its action as conducive to fungal infections. Materials and methods: It was come microscopically to examine cytologically cervico-vaginal smears of 740 patients population of Puebla city-Mexico, stained with the amended Papanicolaou´s method. Results and discussion: Between the 740 examinated patients, 71 of them were IUD´s users and within this group, 25 women were positive to fungal infection (35,2%), while 180 of 669 women IUD´s non-users (26,9%) had fungal infection. Which make it interesting these results, is the fact of having demonstrated that using of IUD promotes fungal colonization in a greater degree that non-users of IUD, though if we take into account to all patients IUD´s users, the percentage of mycoses in them, wasn´t relevant. Conclusion: Controlled use of IUD and need of its removal if required, is very important because IUD works as a route between the vaginal cavity and the uterine, being present at the decrease of uterine content to fornix later and ascent of vaginal flora microorganisms to uterus, being able to cause specifically a fungal infection, in special, by Candida.

REFERENCES

1. Inabo HI. The significance of Candida infections of medical implants. Sci Res Essays 2006; 1: 8-10.

2. Dominic RM, Shenoy S, Baliga S. Candida biofilms in medical devices. Kathmandu Univ Med J. 2007; 5: 431-436.

3. Helen M. Vaginal discharge – causes, diagnosis and treatment. BMJ. 2004; 328: 1306-1308.

4. Lori A. Boerdaman MD. Managing vulvar Infections: HPV-Related Disease and Candidiasis: pathogenesis, risk factors, diagnosis and treatment. Women´s Health Primary Care 2000; 3: 857-862.

5. Demirezen S, Dirlik O, Beksac M.S. The Association of Candida Infection with intrauterine contraceptive device. Eur J Public Health 2005; 13: 32-34.

6. Nabhan A. Vulvovaginal Candidiasis. ASJOG. 2006; 3: 73-79.

7. Krishna A, Usha S, Veena A. Microbial And Cytopathological Study Of Intrauterine Contraceptive Device Users. Indian J Med Sci. 2004; 58: 394-399.

8. Pal Z, Urban E, Dosa E, Pal A, Nagy E. Biofilm formation on intrauterine devices in relation to duration of use. J Med Microbiol. 2005; 54: 1199-1203.

9. Alfuhaid T, Caroline R. Pelvic actinomycosis associated with intrauterine device use: case report. Can Assoc Radiol J. 2003; 54: 160-162.

10. Ghaza M, Musmar M. Effect of IUD (Intrauterine Device) on Reproductive Tract Infection (RTI) in the Northern West Bank. Middle East. J Fam Med. 2004; 5: 1-12.

11. Guillen FM, Moreno F, Lopez M, Omaña UT, Altuve AF, Toro M. Hallazgos microbiológicos cervicovaginales en pacientes de pesquisa de cáncer. Rev Fac Farma 2003; 45 (1): 8-12.

12. Ifeoma BE, Harish C, Okobia R, Bunmi OS. Effect of contraceptives on the prevalence of vaginal colonization with Candida species in Edo State, Nigeria. Rev Iberoam Micol. 2001; 18: 171-173.

13. Torres GS, Schalper C. Kurt C., Pierart ZC. Análisis de la presencia de actinomicosis pélvica en mujeres de una comunidad rural en chile. Rev Chil Obstet Ginecol 2002; 67 (3): 232-236.

14. Manual de procedimientos Sigma. Tinción e Interpretación de la Muestra de Citología Cervical. México, D.F. 2006. p. 29-35.

15. Alona P, Roni G, Potasman I. Candida sepsis following transcervical chorionic villa sampling. Infect Dis Obstet Gynecol. 2001; 9: 147-148.